Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Antibody-based diagnostic and therapeutic innovations for human cancer.

Kramer K, Cheung NK.

Compr Ther. 2001 Fall;27(3):183-94. Review.

PMID:
11569318
2.

Cationization of monoclonal antibodies: another step towards the "magic bullet"?

Vaisitti T, Deaglio S, Malavasi F.

J Biol Regul Homeost Agents. 2005 Jul-Dec;19(3-4):105-12. Review.

PMID:
16602624
3.

Monoclonal antibodies: innovations in diagnosis and therapy.

Baquiran DC, Dantis L, McKerrow J.

Semin Oncol Nurs. 1996 May;12(2):130-41. Review.

PMID:
8727800
5.

Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.

Riethmüller G, Johnson JP.

Curr Opin Immunol. 1992 Oct;4(5):647-55. Review.

PMID:
1418733
6.

Diagnostic and therapeutic use of monoclonal antibodies to human tumor antigens.

Hellström KE, Hellström I, Brown JP.

Med Oncol Tumor Pharmacother. 1984;1(3):143-7. Review.

PMID:
6400036
7.

Monoclonal antibodies in clinical oncology.

Dalle S, Thieblemont C, Thomas L, Dumontet C.

Anticancer Agents Med Chem. 2008 Jun;8(5):523-32. Review.

PMID:
18537534
8.

Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.

Zhang Q, Chen G, Liu X, Qian Q.

Cell Res. 2007 Feb;17(2):89-99. Review.

9.

Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications.

Abrams PG, Morgan AC, Fritzberg R.

Cancer Invest. 1990;8(2):287-8. No abstract available.

PMID:
2400950
10.

[Hybridomas in cancer].

Fernández Cruz E.

Rev Esp Oncol. 1982;29(4):811-9. Spanish.

PMID:
6765424
11.

Antibody-based cancer therapies: back to "polyclonals"?

Paganelli G, De Santis R.

Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1453-5. No abstract available.

PMID:
15258701
12.

[Side effects of monoclonal antibodies in diagnostic and therapeutic applications in cancer].

van der Linden EF, van Kroonenburgh MJ.

Ned Tijdschr Geneeskd. 1988 Nov 5;132(45):2049-52. Review. Dutch. No abstract available.

PMID:
3054580
13.

Antibody-based therapeutics in oncology.

Ross J, Gray K, Schenkein D, Greene B, Gray GS, Shulok J, Worland PJ, Celniker A, Rolfe M.

Expert Rev Anticancer Ther. 2003 Feb;3(1):107-21. Review.

PMID:
12597355
14.

Current status of cancer therapy with radiolabeled monoclonal antibody.

Oriuchi N, Higuchi T, Hanaoka H, Iida Y, Endo K.

Ann Nucl Med. 2005 Jul;19(5):355-65. Review.

PMID:
16164191
16.

Future of monoclonal antibodies in the treatment of hematologic malignancies.

Reff ME, Hariharan K, Braslawsky G.

Cancer Control. 2002 Mar-Apr;9(2):152-66. Review.

17.

Monoclonal antibodies in the management of solid tumors.

Kalofonos HP, Grivas PD.

Curr Top Med Chem. 2006;6(16):1687-705. Review.

PMID:
17017951
18.

Challenges in monoclonal antibody-based therapies.

Samaranayake H, Wirth T, Schenkwein D, Räty JK, Ylä-Herttuala S.

Ann Med. 2009;41(5):322-31. doi: 10.1080/07853890802698842. Review.

PMID:
19234897
19.

Tumor-associated antigens and biomarkers in cancer and immune therapy.

Malyankar UM.

Int Rev Immunol. 2007 May-Aug;26(3-4):223-47. Review.

PMID:
17558745
20.

Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies.

Satoh M, Iida S, Shitara K.

Expert Opin Biol Ther. 2006 Nov;6(11):1161-73. Review.

PMID:
17049014
Items per page

Supplemental Content

Support Center